FDA Inspection 1257338 — Shanghai Anbison Lab Co., Ltd.
The FDA completed an inspection of Shanghai Anbison Lab Co., Ltd. on Oct 11, 2024 in Shanghai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 11, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shanghai (China)
Additional Details
Bioanalytical BA/BE